Hematology Analyzer Market Report – Research, Industry Analysis Reports and Market Demands

Global Hematology Analyzer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Hematology Analyzer Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Three-part Differential
- 1.3.3 Five-part Differential
1.4 Market Analysis by Application Scenario
- 1.4.1 Overview: Global Hematology Analyzer Consumption Value by Application Scenario: 2021 Versus 2025 Versus 2032
- 1.4.2 Clinical
- 1.4.3 Screening
- 1.4.4 Research
- 1.4.5 Other
1.5 Market Analysis by System Form
- 1.5.1 Overview: Global Hematology Analyzer Consumption Value by System Form: 2021 Versus 2025 Versus 2032
- 1.5.2 Benchtop
- 1.5.3 Floor-standing
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Hematology Analyzer Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Public Hospitals
- 1.6.3 Third-party Independent Laboratory
- 1.6.4 Other
1.7 Global Hematology Analyzer Market Size & Forecast
- 1.7.1 Global Hematology Analyzer Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Hematology Analyzer Sales Quantity (2021-2032)
- 1.7.3 Global Hematology Analyzer Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Hematology Analyzer by Manufacturer

3.1 Global Hematology Analyzer Sales Quantity by Manufacturer (2021-2026)
3.2 Global Hematology Analyzer Revenue by Manufacturer (2021-2026)
3.3 Global Hematology Analyzer Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Hematology Analyzer by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Hematology Analyzer Manufacturer Market Share in 2025
- 3.4.3 Top 6 Hematology Analyzer Manufacturer Market Share in 2025
3.5 Hematology Analyzer Market: Overall Company Footprint Analysis
- 3.5.1 Hematology Analyzer Market: Region Footprint
- 3.5.2 Hematology Analyzer Market: Company Product Type Footprint
- 3.5.3 Hematology Analyzer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Hematology Analyzer Market Size by Region
- 4.1.1 Global Hematology Analyzer Sales Quantity by Region (2021-2032)
- 4.1.2 Global Hematology Analyzer Consumption Value by Region (2021-2032)
- 4.1.3 Global Hematology Analyzer Average Price by Region (2021-2032)
4.2 North America Hematology Analyzer Consumption Value (2021-2032)
4.3 Europe Hematology Analyzer Consumption Value (2021-2032)
4.4 Asia-Pacific Hematology Analyzer Consumption Value (2021-2032)
4.5 South America Hematology Analyzer Consumption Value (2021-2032)
4.6 Middle East & Africa Hematology Analyzer Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Hematology Analyzer Sales Quantity by Type (2021-2032)
5.2 Global Hematology Analyzer Consumption Value by Type (2021-2032)
5.3 Global Hematology Analyzer Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Hematology Analyzer Sales Quantity by Application (2021-2032)
6.2 Global Hematology Analyzer Consumption Value by Application (2021-2032)
6.3 Global Hematology Analyzer Average Price by Application (2021-2032)

7 North America

7.1 North America Hematology Analyzer Sales Quantity by Type (2021-2032)
7.2 North America Hematology Analyzer Sales Quantity by Application (2021-2032)
7.3 North America Hematology Analyzer Market Size by Country
- 7.3.1 North America Hematology Analyzer Sales Quantity by Country (2021-2032)
- 7.3.2 North America Hematology Analyzer Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Hematology Analyzer Sales Quantity by Type (2021-2032)
8.2 Europe Hematology Analyzer Sales Quantity by Application (2021-2032)
8.3 Europe Hematology Analyzer Market Size by Country
- 8.3.1 Europe Hematology Analyzer Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Hematology Analyzer Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Hematology Analyzer Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Hematology Analyzer Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Hematology Analyzer Market Size by Region
- 9.3.1 Asia-Pacific Hematology Analyzer Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Hematology Analyzer Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Hematology Analyzer Sales Quantity by Type (2021-2032)
10.2 South America Hematology Analyzer Sales Quantity by Application (2021-2032)
10.3 South America Hematology Analyzer Market Size by Country
- 10.3.1 South America Hematology Analyzer Sales Quantity by Country (2021-2032)
- 10.3.2 South America Hematology Analyzer Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Hematology Analyzer Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Hematology Analyzer Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Hematology Analyzer Market Size by Country
- 11.3.1 Middle East & Africa Hematology Analyzer Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Hematology Analyzer Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Hematology Analyzer Market Drivers
12.2 Hematology Analyzer Market Restraints
12.3 Hematology Analyzer Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Hematology Analyzer and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hematology Analyzer
13.3 Hematology Analyzer Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Hematology Analyzer Typical Distributors
14.3 Hematology Analyzer Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Hematology Analyzer market size was valued at US$ 1388 million in 2025 and is forecast to a readjusted size of US$ 1855 million by 2032 with a CAGR of 4.2% during review period.
A hematology analyzer is a core in-vitro diagnostic device used to automatically detect, classify, and analyze red blood cells, white blood cells, platelets, hemoglobin, and related hematological parameters in human blood samples. The device typically integrates sample loading, cell counting, white blood cell differentiation, abnormality flagging, quality control management, and data output. It is widely used in hospital laboratories, emergency departments, health examination centers, independent medical laboratories, and primary healthcare institutions. With the development of optical detection, flow cytometry, fluorescence staining, digital imaging, and intelligent algorithms, hematology analyzers have evolved from traditional standalone testing instruments into important platforms connecting clinical diagnosis, laboratory automation, and medical data management. They are fundamental diagnostic tools for disease screening, infection assessment, anemia evaluation, hematological disease monitoring, and treatment follow-up.In 2025, global hematology analyzer production reached approximately 111.93 k units and price is about 12.05 k USD/Unit.The average gross profit margin of this product is 45%.
Hematology analyzers are essential diagnostic devices with high testing frequency, broad clinical coverage, and stable demand. Market opportunities are driven by rising healthcare service volume, laboratory capability upgrades, equipment replacement, and the advancement of high-end domestic medical devices. As medical institutions demand higher testing efficiency, greater accuracy, automatic reflex testing, and intelligent result review, hematology analyzers are shifting from simply completing tests to improving overall laboratory operation efficiency. Large hospitals focus on high throughput, automation line integration, and information management, while primary healthcare institutions require stable, easy-to-use devices with controllable maintenance costs. Policy support for medical equipment renewal, county-level healthcare capacity building, and domestic medical equipment development further strengthens the industry’s long-term growth logic. For manufacturers, companies capable of providing integrated instruments, reagents, quality control materials, software, and services are better positioned to build customer stickiness and recurring revenue streams.
Competition in the hematology analyzer market is shifting from standalone device competition to system capability competition. Companies face multiple challenges, including technology upgrades, pricing pressure, channel penetration, and service network development. High-end hospital customers have strict requirements for testing stability, abnormal cell identification, automation line compatibility, and laboratory information system connectivity, creating relatively high entry barriers. In the mid- and low-end markets, manufacturers are more exposed to tender price reductions, domestic brand competition, and distributor margin compression. Meanwhile, hematology analyzers are closely linked with reagents, calibrators, quality control materials, and after-sales service. If a company lacks strength in core components, reagent consistency, algorithm capability, or engineering service coverage, the long-term user experience may be affected. In the future, only companies with systematic advantages in product reliability, testing performance, supply chain stability, and lifecycle service will be able to maintain strong resilience in competition.
Downstream demand is becoming increasingly segmented, scenario-based, and system-oriented. Tertiary hospitals and large regional laboratory centers prefer high-throughput, automated hematology systems that can be connected to laboratory automation lines, helping improve sample processing efficiency, reduce manual review workload, and strengthen quality control. Secondary hospitals and county-level medical institutions place greater emphasis on product stability, testing speed, ease of maintenance, and total cost of ownership. Primary healthcare providers, community health centers, and health examination institutions prefer compact, easy-to-operate devices suitable for routine screening. Independent medical laboratories have higher requirements for large-scale testing, continuous device operation, and information system integration. Overall, customer purchasing logic is shifting from comparing device prices alone to evaluating testing performance, reagent supply, quality control systems, after-sales response, and digital management capabilities.
The upstream supply chain of hematology analyzers mainly includes precision mechanical components, optical detection modules, fluid control systems, electronic components, sensors, pumps and valves, tubing, embedded software, detection algorithms, and reagent raw materials. Among these, optical systems, fluidic systems, flow detection channels, core sensors, and algorithm software directly determine testing accuracy, repeatability, stability, and abnormality flagging capability, making them important sources of technical barriers. As the domestic medical device supply chain continues to mature, local supporting capabilities for certain structural parts, general electronic components, and basic reagent materials are improving. However, high-end optical components, precision fluidic parts, core chips, highly consistent reagent systems, and intelligent analysis software still require strong R&D and quality control capabilities. In the future, companies with stronger upstream control will be better positioned to optimize costs, secure delivery, and accelerate product iteration.
This report is a detailed and comprehensive analysis for global Hematology Analyzer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hematology Analyzer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Hematology Analyzer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Hematology Analyzer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Hematology Analyzer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hematology Analyzer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hematology Analyzer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Danaher, Abbott Laboratories, Siemens Healthineers, HORIBA, Boule Diagnostics AB, Nihon Kohden, BioSystems, Diatron, Mindray Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hematology Analyzer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Three-part Differential
Five-part Differential
Market segment by Application Scenario
Clinical
Screening
Research
Other
Market segment by System Form
Benchtop
Floor-standing
Market segment by Application
Public Hospitals
Third-party Independent Laboratory
Other
Major players covered
Sysmex Corporation
Danaher
Abbott Laboratories
Siemens Healthineers
HORIBA
Boule Diagnostics AB
Nihon Kohden
BioSystems
Diatron
Mindray Medical
DYMIND
Urit Medical
Zybio
Dirui Medical
Maccura
Sinnowa
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hematology Analyzer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hematology Analyzer, with price, sales quantity, revenue, and global market share of Hematology Analyzer from 2021 to 2026.
Chapter 3, the Hematology Analyzer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hematology Analyzer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hematology Analyzer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hematology Analyzer.
Chapter 14 and 15, to describe Hematology Analyzer sales channel, distributors, customers, research findings and conclusion.

Buy now